Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial
在绝经后骨质疏松症女性中多次使用硬骨素单克隆抗体SHR-1222：一项随机、双盲、安慰剂对照、剂量递增的1期试验
期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2023.1168757
Dai, Zhijie; Zhu, Ronghua; Sheng, Zhifeng; Qin, Guijun; Luo, Xianghang; Qin, Qun; Song, Chunli; Li, Liping; Jin, Ping; Yang, Guoping; Cheng, Yanxiang; Peng, Danhong; Zou, Chong; Wang, Lijuan; Shentu, Jianzhong; Zhang, Qin; Zhang, Zhe; Yan, Xiang; Fang, Pingfei; Yan, Qiangyong; Yang, Lingfeng; Fan, Xiao; Liu, Wei; Wu, Bo; Cui, Rongrong; Wu, Xiyu; Xie, Yuting; Shu, Chang; Shen, Kai; Wei, Wenhua; Lu, Wei; Chen, Hong; Zhou, Zhiguang
